Correction to: Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Clinical Excellence Single Technology Appraisal
Crossref DOI link: https://doi.org/10.1007/s40273-018-0635-4
Published Online: 2018-02-24
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tikhonova, Irina A.
Jones-Hughes, Tracey
Dunham, James
Warren, Fiona C.
Robinson, Sophie
Stephens, Peter
Hoyle, Martin
Text and Data Mining valid from 2018-02-24
Article History
First Online: 24 February 2018